Article
Selective Inactivation of Astrocytic Monoacylglycerol Lipase for Alzheimer’s Disease Therapy
2025-12-09
Abstract excerpt
Alzheimer’s disease (AD) is the leading cause of dementia in the elderly, yet effective therapies remain lacking. Here, we identify monoacylglycerol lipase (MAGL), the principal enzyme that degrades the endocannabinoid 2-arachidonoylglycerol (2-AG) in the brain, specifically in astrocytes as a promising therapeutic target for AD. APP transgenic (TG) mice with astrocyte-specific MAGL deletion (TG-aKO), but not neur...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d859e668-dec5-56fe-a990-80c9faba6d81
- DOI
- 10.64898/2025.12.04.692105
